Jan 13,2021 03:17 PM
Torrent Pharma, Biocon, Divi's Labs and Sun Pharma were among the top drags on the pharma index.
Alkem Laboratories Ltd stays supported Dec 30,2020
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||569.80||47.44||136,714.11||724.81||0.70||3,207.24||106.10|
|Divis Laboratories Ltd||3,483.05||52.60||92,486.60||513.30||0.46||1,713.78||313.47|
|Dr Reddys Laboratories Ltd||4,909.30||33.24||81,633.35||481.00||0.51||3,333.60||979.38|
|Aurobindo Pharma Ltd||959.60||21.13||56,217.88||801.54||0.31||4,425.43||246.88|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 700 b... More
Reports by alkem-laboratories-ltd-share-price
Jan 27, 2021 08:28 PM
The company’s consolidated revenue in the period stood at Rs1,918.92cr, up 3.22% yoy and 15.66% qoq.
06 Nov 2020
28 Oct 2020
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is ... More
18 Aug 2020
05 Jun 2020
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia:Fixed that th... More
05 Jun 2020
10 Aug 2020
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia:recommended a... More